Anti-inflammatory drug therapy in asthma

Paediatric Respiratory Reviews

Volumn 10, Issue 4, 2009, Pages 214-219

  Rottier, Bart L ^a   Duiverman, Eric J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Asthma; Cromones; Inhaled corticosteroids; Leukotriene receptor antagonists; Macrolides; Preschool wheeze; Theophylline

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ASTHMA; CHILD; HUMAN; INHALATIONAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, INHALATION; ANTI-INFECTIVE AGENTS; ASTHMA; CHILD; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS;

EID: 76549128803     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2009.06.007     Document Type: Review

References (53)

1. Kay A.B. Allergy and allergic diseases. First of two parts. N Engl J Med 2001, 344:30-37.
2. Larche M., Robinson D.S., Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003, 111:450-464.
3. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma; 2007.
4. Global Strategy for Asthma Management and Prevention 2008 (update), ; 2008. http://www.ginasthma.org/.
5. British Guideline on the Management of Asthma; British Thoracic Society Scottish Intercollegiate Guidelines Network Thorax 2008; 63 (Supplement 4): 1-121.
6. Barnes P.J. Corticosteoid effects on cell signalling. Eur Respir J 2006, 27:413-426.
7. Visser M.J., van der Veer E., Postma D.S., et al. Side effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004, 24:420-425.
8. Visser M.J., Postma D.S., Arends L.R. One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma. Am J Respir Crit Care Med. 2001, 164:2073-2077.
9. Colice G.L. New developments in inhaled corticosteroids. Allergy and Asthma 2006, 27:332-340.
10. Gulliver T., Morton R., Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Pediatr Drugs 2007, 9:185-194.
11. Derendorf H., Nave R., Drollmann A., Cerasoli F., Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Review. Eur Respir J 2006, 28:1042-1050.
12. Brand P.L.P., Baraldi E., Bisgaard H., et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008, 32:1096-1110.
13. Silverman M., Wang M., Hunter G., Taub N. Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis. Thorax 2003, 58:431-434.
14. Panickar J.R., Grigg J. Controversies in the management of preschool viral wheeze. Paediatric Respiratory Reviews 2006, 7:293-298.
15. Schokker S., Kooi E.M.W., Vries de R.W., et al. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial. Pulm Pharmacol Ther 2008, 21:88-97.
16. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006, 354(19):1985-1997.
17. Bisgaard H., Hermansen M.N., Loland L., et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006, 354:1998-2005.
18. The Childhood Asthma Management Program Research Group. Long-term Effects of Budesonide or Nedocromil in Children with Asthma. N Engl J Med 2008; 343: 1054-1063.
19. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2001; 164(11):2107-13. Erratum in: Am J Respir Crit Care Med. 2002; 166(8):1143.
20. van den Toorn L.M., Prins J.B., de Jongste J.C., et al. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respir Med. 2005, 99(6):779-787.
21. Rasmussen F.S.H.C., Lambrechtsen J., Hansen H.S., Hansen N.C. Impact of airway lability, atopy, and tobacco smoking on the development of asthma-like symptoms in asymptomatic teengares. Chest 2000, 117:1-9.
22. Plaschke P., Janson C., Norman E., Bjornsson E., Ellbjar S., Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000, 162:920-924.
23. Kerstjens H., Overbeek S., Schouten J., Brand P., Postma D. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled budesonide. Eur Respir J 1993, 6:868-876.
24. Pedersen B., Dahl R., Karlstrom R., Peterson C., Venge P. Eosinophil and neutrphil activity in asthma in one-year trial with inhaled budesonide. Am J Respir Crit Care Med 1996, 153:1519-1529.
25. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002, 57:226-230.
26. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003, 168:1308-1311.
27. Livingston E., Chaudhuri R., McMahon A.D., Frase I., Mc Sharry C.P., Thomson N.C. Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respi J 2007, 29:64-70.
28. Thomson N.C., Chauderhuri R., Livingston E. Asthma and cigarette smoking. Review. Eur Respir J 2004, 24:822-833.
29. Peat J.K., Woolcock A.J., Cullen K. rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987, 70:171-179.
30. Ulrik C.S., Backer V., Dirksen A., et al. Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up. Respir Med 1995, 89:547-554.
31. Dijkstra A., Vonk J.M., Jongepier H., et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006, 61:105-110.
32. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systemic review and meta-analysis. Arch Intern Med 1999, 159:941-955.
33. Allen D.B. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006, 53:101-110.
34. Agertoft L., Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000, 343:1064-1069.
35. Vries de T.W., Roon van E.N., Duiverman E.J. Inhaled corticosteroids do not affect behaviour. Acta Paediatr 2008, 97:786-789.
36. Gyllfors P., Dahlen S.E., Kumlin M., Lasrsson K., Dahlen B. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone prprionate. J Allergy Clin Immunol 2006, 118:78-83.
37. Straub D.A., Minocchien S., Moeller A., et al. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest 2005, 127:509-514.
38. Bisgaard H., Zielen S., Garcia-Garcia M., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with inetrmittent asthma. Am J Respir Crit Care Med 2005, 171:315-32237.
39. Bisgaard H., Flores-Nunez A., Goh A., et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008, 178(8):854-860.
40. Kooi E.M., Schokker S., Boezen Marike H., et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: randomized controlled trial. Pulm Pharmacol Ther 2008.
41. Joos S., Miksch A., Szecsenyi J., et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008, 63(5):453-462.
42. Shinkai M., Henke M.O., Rubin B.K. Macrolide antibiotics as immunomodulatory medications: proposed mechanism of action. Pharm Therapeut 2008, 117:393-405.
43. Martin R.J., Kraft M., Chu H.W., Berns E.A., CAssell G.H. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001, 107:595-601.
44. Giamarellos-Bourboulis E.J. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicr Agents 2008, 31(1):12-20.
45. Richeldi L, Ferrara G, FAbbri L, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002997.
46. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-63.
47. Rytila P., Pelkonen A.S., Metso T., Nikander K., Haahtela T., Turpeinen M. Induced sputum in children with newly diagnosed mild asthma: The effect of 6 months of treatment with budesonide or disodium cromoglycate. Allergy 2004, 59(8):839-844.
48. Tasche M.J., Uijen J.H., Bernsen R.M., et al. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 2000, 55:913-920.
49. Hendeles L, Weinberger M. Theophylline use in asthma. Up to date; accessed Jan 6, 2009.
50. Ito K., Lim S., Caramori G., Cosio B., Chung K.F., Adcock I.M., Barnes P.J. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A 2002, 99(13):8921-8926.
51. Guss S., Portnoy J. Methotrexate treatment of severe asthma in children. Pediatrics. 1992, 89:635-639.
52. Coren M.E., Rosenthal M., Bush A. The use of cyclosporin in corticosteroid dependent asthma. Arch Dis Child. 1997, 77(6):522-523.
53. Holgate S.T., Polosa R. Treatment strategies for allergy and asthma. Nature Rev Imm 2008, 8:218-230.